Navigation Links
Zimmer Announces Actions Affecting its Ohio-based Orthopaedic Surgical Products Operation
Date:4/3/2008

Voluntarily Recalls and Temporarily Suspends Production of Certain Patient

Care Product Lines

WARSAW, Ind., April 3, 2008 /PRNewswire-FirstCall/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SWX: ZMH) announced today that it has taken a number of actions to improve quality systems at its Dover, Ohio facility, which manufactures Zimmer Orthopaedic Surgical Products (OSP).

The Company recently conducted a review of quality systems at the Dover, Ohio OSP facility and initiated voluntary product recalls of certain OSP products manufactured at the Dover facility that the Company has determined do not meet internal quality standards. In addition, the Company has voluntarily and temporarily suspended production and sales of certain OSP products manufactured at the Dover facility. The suspension will permit the Company to focus the OSP organization on the needed improvements to manufacturing and conduct enhanced quality training for employees.

The Company has notified the U.S. Food and Drug Administration (FDA), distributors and end-users of the recalls. These recalls do not affect the Company's core hip and knee implants business.

The OSP division produces a variety of patient care items used to support orthopaedic surgery, including disposables used in blood management, surgical wound site debridement and cement accessories. In 2007, Zimmer reported revenues from its OSP and Other product category of $234 million, less than half of which were generated by products affected by the recalls and suspension. These actions are expected to adversely impact 2008 OSP revenues by $70 to $80 million. Additional detail on the expected impact will be provided during the Company's first quarter investor conferenc
'/>"/>

SOURCE Zimmer Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Zimmer Holdings Offer and ORTHOsoft Directors Circular Mailed to Shareholders
2. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2007 Results
3. Zimmer Announces Successful Completion of ORTHOsoft Takeover Bid
4. Zimmer Holdings to Present at Upcoming Investor Conferences
5. Ray Elliott to Retire as Chairman of Zimmer Holdings; John McGoldrick to Serve as Non-Executive Chairman
6. Zimmer Holdings Receives FDA Approval to Market Mobile Bearing Knee
7. Zimmer Holdings to Present at JPMorgan Healthcare Conference
8. Zimmer Holdings Announces Webcast and Conference Call of Fourth Quarter and Full-Year 2007 Results
9. Zimmer Spine Introduces New Rigid to Dynamic Stabilization Transition System
10. Zimmer Reports Fourth Quarter and 2007 Financial Results
11. Zimmer Holdings to Present at Merrill Lynch Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...er & Olsen LLP has filed a,class action lawsuit ag..."Company") (Nasdaq: ARTC ) and certain of its off...istrict of Texas on behalf of all persons or,entit... January 24, 2008,through July 18, 2008 (the "Comm...or entities who purchased call options or sold put...
(Date:7/25/2008)... therapy may be due to genetic factors , ... challenges the long-held belief that the hepatiti...y to restore itself after HIV patients are treated.... , From 50 percent to 90 percent of HIV-infect...ous drug use is the main cause of both types of in...
(Date:7/25/2008)...ity.com announces the,availability of Trade Alerts... all of the daily trading notes for free by visiti...erts include: DUSA Pharmaceuticals Inc. (Nasdaq: ... MBRK ), NovaMed Inc. (Nasdaq:,NOVA), Adolor Corp....) and,Abaxis Inc. (Nasdaq: ABAX )., Join investo...
(Date:7/25/2008)...mprovements in Members, Health, ATLANTA, July 25 ...h,care quality management solutions for health pla...nto a long-term agreement with Wellmark, Inc. to,c...lity(SM) Incent and,Reward Best Practices initiati...are clinicians to promote improved quality health ...
Breaking Medicine News(10 mins):Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 2Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 3Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3
...ypothermia by following a few tips on dressing wel...o feel you've got to stay indoors when the weather...ll do you a lot of good.// But it's important to d...ts of cold weather. Just putting on a woolly scarf...
...ng to a recent survey, researchers suggests that n...rgery assessments of patients to the same degree o...in the UK// and it's been suggested that appropria...some of their roles. Researchers in Ireland, UK, h...
...ng to a latest research it has been observed that ...d three quarters of teenage girls in juvenile dete...der. In a recent study, 2023 juvenile teens were ...hey were admitted to a temporary juvenile detentio...
...ng to a recent study it has been observed that yog...condition of those with heart disease. Yoga exerci...iritual //health - or so it is claimed. Researcher...and, reviewed the best evidence they could find on...
Other Medicine News:
(Date:7/22/2008)...a multi-center 293-patient European, trial -, h...ymbol: CYT, MONTREAL, July 22 /PRNewswire-FirstCa...ader in cryotherapy products to treat cardiac,arrh...resented from three,European study centers using t...ublished earlier today in the Journal of the Ameri...
(Date:7/22/2008)...s Development Initiative bring MJFF,s,current acti...nuary 20,2009, NEW YORK, July 22 /PRNewswire-USN...ry of transformative treatments and a cure for Par...r Parkinson,s Research has awarded,$2.7 million in... awards,were granted under MJFF,s Therapeutics Dev...
(Date:7/22/2008)...nd Efficacy of Treating Patients with ... and YONGIN-SI, South Korea, July 22 /PRNewswire/ ...ntario), and its South,Korean partner Green Cross ...Phase I clinical trial of its first-in-class lead ...ell-tolerated and resulted in clear,anti-cancer ef...
(Date:7/22/2008)... and Apidra(R) Resulted in Significant, Reductions... the Algorithm Us...sults from the "Adjust to,Target in Type 2 Diabete...e,Counting for Adjustment of Mealtime Insulin Glul...tes Association,s (ADA) medical journal,Diabetes ...
Breaking Medicine Technology:CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed Refractory CLL Who Achieve Complete Remission 1016 1Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed Refractory CLL Who Achieve Complete Remission 1016 2Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed Refractory CLL Who Achieve Complete Remission 1016 3Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed Refractory CLL Who Achieve Complete Remission 1016 4Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed Refractory CLL Who Achieve Complete Remission 1016 5Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed Refractory CLL Who Achieve Complete Remission 1016 6TREANDA Demonstrates Substantial Efficacy in Patients with Relapsed Indolent Non Hodgkins Lymphoma 1012 1TREANDA Demonstrates Substantial Efficacy in Patients with Relapsed Indolent Non Hodgkins Lymphoma 1012 2TREANDA Demonstrates Substantial Efficacy in Patients with Relapsed Indolent Non Hodgkins Lymphoma 1012 3TREANDA Demonstrates Substantial Efficacy in Patients with Relapsed Indolent Non Hodgkins Lymphoma 1012 4TREANDA Demonstrates Substantial Efficacy in Patients with Relapsed Indolent Non Hodgkins Lymphoma 1012 5Private Equity Firms Acquire American Laser Centers 7939 1Private Equity Firms Acquire American Laser Centers 7939 2Brooks and the University of Florida Reach Research Agreement 7935 1Brooks and the University of Florida Reach Research Agreement 7935 2
...merican Academy of Neurology Annual Meeting,Show A...res, BOSTON, May 01, 2007 /PRNewswire/ -- Data fro...can Academy of Neurology (AAN),meeting suggest tha...ormulation of Lamictal(R) (lamotrigine) is effecti...ilepsy with and without,secondary generalization. ...
...omen published today shows reduction of 70,percent...s, EAST HANOVER, N.J., May 02, 2007 /PRNewswire/ -...c acid) Injection significantly,reduced the incide...er three years in women with postmenopausal osteop...land Journal of Medicine,marks the first time tha...
Other Medicine Technology:New Data Shows Once a Day Lamictal XR is Effective in Treating,Patients with Partial Seizures 2New Data Shows Once a Day Lamictal XR is Effective in Treating,Patients with Partial Seizures 3New Data Shows Once a Day Lamictal XR is Effective in Treating,Patients with Partial Seizures 4New Data Shows Once a Day Lamictal XR is Effective in Treating,Patients with Partial Seizures 5Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 2Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 3Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 4Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 5Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 6
Specially designed for rugged use; perfect tool with power and endurance. Balance of weight and power helps reduce user fatigue. Internally lubricated for longer serivce. Switch is designed and place
De Soutter supply clean cast removal saws that are low in voltage and contain an integrated extractor system, combining state-of-the-art ergonomics with performance and durability.
...he osteotomy staples is quite similar to the type ...e the inner position of the anti recoil contours a...lique staples). There are 3 kinds of staples: 1.... staples can have 3 different widths: 20mm, 26 mm ...
...e Barium Sulfate USP is specifically designed to p...pabilities for todays medical professionals who ad...y. Comprised of a uniform particle size, Biotrace ...lting in a consistent visualization of bone cement...
Medicine Products: